<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03199014</url>
  </required_header>
  <id_info>
    <org_study_id>WestChinaH-CVD-001</org_study_id>
    <nct_id>NCT03199014</nct_id>
  </id_info>
  <brief_title>the Effect of Prolonged Inflation Time During Stents Deployment for ST-elevation Myocardial Infarction</brief_title>
  <official_title>the Effect of Prolonged Inflation Time During Drug-eluting Stents Deployment Compared With Conventional Method for ST-elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether prolonged inflation time on drug-eluting
      stents deployment for ST-elevation myocardial Infarction was better than conventional stents
      deployment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With TIMI 3</measure>
    <time_frame>1 minute after sent was deployed</time_frame>
    <description>TIMI 0 flow (no perfusion) refers to the absence of any antegrade flow beyond a coronary occlusion.TIMI 1 flow (penetration without perfusion) is faint antegrade coronary flow beyond the occlusion, with incomplete filling of the distal coronary bed.TIMI 2 flow (partial reperfusion) is delayed or sluggish antegrade flow with complete filling of the distal territory.TIMI 3 is normal flow which fills the distal coronary bed completely</description>
  </primary_outcome>
  <primary_outcome>
    <measure>corrected TIMI frame count(frames)</measure>
    <time_frame>1 minute after sent was deployed</time_frame>
    <description>Grading was done on cinefilm at 15frames/s made in a Philips digital coronary imaging catheterization laboratory.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>myocardial blush grade</measure>
    <time_frame>1 minute after sent was deployed</time_frame>
    <description>0, no myocardial blush or contrast density; 1, minimal myocardial blush or contrast density; 2,moderate myocardial blush or contrast density but less than that obtained during angiography of a contralateral or ipsilateral non- infarct-related coronary artery; and 3, normal myocardial blush or contrast density, comparable with that obtained during angiography of a contralateral or ipsilateral non-infarct-related coronary artery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants ST-segment resolution</measure>
    <time_frame>60min after the operation</time_frame>
    <description>1, normalized, defined as no residual ST-segment elevation; 2, improved, defined as a residual ST-segment elevation ,70% of with that on the first ECG; and 3, unchanged, defined as a residual ST-segment elevation 70% of that on the first ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Death from cardiac causes</measure>
    <time_frame>one month after the operation</time_frame>
    <description>death from acute myocardial infarction, cardiac perforation, or pericardial tamponade; an arrhythmia or conduction abnormality; complications of the interventional procedure at baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Target-vessel revascularization</measure>
    <time_frame>one month after the operation</time_frame>
    <description>any revascularization intervention (PCI or CABG) occurring in a treated vessel at any time after the index intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants stent thrombosis</measure>
    <time_frame>one month after the operation</time_frame>
    <description>evidence of any myocardial infarction with angiographic confirmation of in-stent thrombus or unexplained death within 30 days after the procedure as stent thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants had Major bleeding</measure>
    <time_frame>one month after the operation</time_frame>
    <description>any symptomatic intracranial hemorrhage, or clinically overt signs of hemorrhage (including imaging) associated with a drop in hemoglobin of&gt;= g/dL (or when the hemoglobin concentration is not available, an absolute drop in hematocrit of&gt;=15%)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Procedural time</measure>
    <time_frame>form start puncturing vascular until the operation was completed intraoperative</time_frame>
    <description>minute</description>
  </other_outcome>
  <other_outcome>
    <measure>Radiation exposure time</measure>
    <time_frame>form start puncturing vascular until the operation was completed intraoperative</time_frame>
    <description>minute</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute ST-elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>prolonged deployment strategy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in &quot;deploying the Drug-eluting Stents with a prolonged time&quot; group,the inflation time was more than 30 seconds when the Drug-eluting Stents deploying,unless the patients was unstable.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rapid deployment strategy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in &quot;deploying the Drug-eluting Stents with a conventional time&quot; group, a conventional method was used to deploying drug-eluting stents,the actual inflation time was within 10s determined by interventional cardiologist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>deploying the Drug-eluting Stents with a prolonged time</intervention_name>
    <description>the inflation time was more than 30 seconds when the Drug-eluting Stents deploying.The PROMUS Element Plus Stent or Co-Cr sirolimus-eluting coronary stent system（GuReater）was used in this study</description>
    <arm_group_label>prolonged deployment strategy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>deploying the Drug-eluting Stents with a conventional time</intervention_name>
    <description>the actual inflation time was within 10s determined by interventional cardiologist.The PROMUS Element Plus Stent or Co-Cr sirolimus-eluting coronary stent system（GuReater）was used in this study</description>
    <arm_group_label>rapid deployment strategy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women ≥18 years with ST-elevation Myocardial Infarction;

          -  patients with STEMI and ischemic symptoms of less than 12 hours'duration;

          -  patients with STEMI and ischemic symptoms of less than 12 hours' duration who have
             contraindications to fibrinolytic therapy, irrespective of the time delay from FMC;

          -  patients with STEMI if there is clinical and/or ECG evidence of ongoing ischemia
             between 12 and 24 hours after symptom onset;

          -  when angiography was completed, guide wire could cross the lesion in the culprit
             vessel, TIMI≥1，with feasibility to direct stenting

        Exclusion Criteria:

          -  cardiac shock, or acute severe heart failure;

          -  the lesion was highly calcified, excessive proximal tortuosity,left main artery
             lesion, restenosis lesion,vein graft lesion,total occlusions;

          -  True bifurcation lesions;

          -  Stenosis≤50% and TIMI flow grade 3;

          -  history of PCI in target vessel;

          -  diameter of the target vessel less than 2 mm;

          -  severe liver and kidney dysfunction;

          -  inability to give informed written consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>He yong</last_name>
    <role>Study Director</role>
    <affiliation>west china hospital of sichuan univercity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>He yong</last_name>
    <phone>+8618980602038</phone>
    <email>zznnyeah@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>West China Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>621000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>He yong</last_name>
      <phone>+8618980602038</phone>
      <email>zznnyeah@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Sabatier R, Hamon M, Zhao QM, Burzotta F, Lecluse E, Valette B, Grollier G. Could direct stenting reduce no-reflow in acute coronary syndromes? A randomized pilot study. Am Heart J. 2002 Jun;143(6):1027-32.</citation>
    <PMID>12075259</PMID>
  </reference>
  <reference>
    <citation>Ozdemir R, Sezgin AT, Barutcu I, Topal E, Gullu H, Acikgoz N. Comparison of direct stenting versus conventional stent implantation on blood flow in patients with ST-segment elevation myocardial infarction. Angiology. 2006 Aug-Sep;57(4):453-8.</citation>
    <PMID>17022381</PMID>
  </reference>
  <reference>
    <citation>Li C, Zhang B, Li M, Liu J, Wang L, Liu Y, Wang Z, Wen S. Comparing Direct Stenting With Conventional Stenting in Patients With Acute Coronary Syndromes: A Meta-Analysis of 12 Clinical Trials. Angiology. 2016 Apr;67(4):317-25. doi: 10.1177/0003319715585662. Epub 2015 May 11.</citation>
    <PMID>25964649</PMID>
  </reference>
  <reference>
    <citation>Hovasse T, Mylotte D, Garot P, Salvatella N, Morice MC, Chevalier B, Pichard A, Lefèvre T. Duration of balloon inflation for optimal stent deployment: five seconds is not enough. Catheter Cardiovasc Interv. 2013 Feb;81(3):446-53. doi: 10.1002/ccd.23343. Epub 2012 Jan 10.</citation>
    <PMID>22109977</PMID>
  </reference>
  <reference>
    <citation>van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998 Jun 16;97(23):2302-6.</citation>
    <PMID>9639373</PMID>
  </reference>
  <reference>
    <citation>Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, Cannon CP, Van de Werf F, Braunwald E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation. 1999 Apr 20;99(15):1945-50.</citation>
    <PMID>10208996</PMID>
  </reference>
  <reference>
    <citation>Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996 Mar 1;93(5):879-88.</citation>
    <PMID>8598078</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2017</study_first_posted>
  <last_update_submitted>July 4, 2017</last_update_submitted>
  <last_update_submitted_qc>July 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Yong He</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

